Valuation: Izotropic Corporation

Market Cap 7.24M 6.49M 5.97M 5.41M 10.1M 688M 10.29M 71.14M 28.56M 362M 27.18M 26.6M 1.14B P/E 2027 *
-
P/E 2028 * -
Enterprise Value 7.24M 6.49M 5.97M 5.41M 10.1M 688M 10.29M 71.14M 28.56M 362M 27.18M 26.6M 1.14B EV / Sales 2027 *
1.45x
EV / Sales 2028 * 0.72x
Free-Float
92.33%
Yield 2027 *
-
Yield 2028 * -
1 month-30.00%
3 months-44.00%
6 months-55.56%
Current year-50.00%
1 week 0.14
Extreme 0.14
0.15
1 month 0.14
Extreme 0.14
0.19
Current year 0.14
Extreme 0.14
0.33
1 year 0.14
Extreme 0.14
0.47
3 years 0.04
Extreme 0.035
0.49
5 years 0.04
Extreme 0.035
1.13
10 years 0.04
Extreme 0.035
1.56
Manager TitleAgeSince
Chief Executive Officer 73 31/05/2023
Director of Finance/CFO 75 31/12/2022
Chief Operating Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member 73 18/05/2016
Director/Board Member 51 21/05/2017
Director/Board Member 71 30/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/09/25 Option

Chief Financial Officer

100,000 0.1761%
18/09/25 Option

Chief Financial Officer

100,000 0.1761%
17/09/25 Sell

Chief Financial Officer

100,000 0.1761%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-68.89%-26.32% 7.26M
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-.--%+2.46%-11.69%-7.41% 53.31B
-2.57%+3.30%+11.59%+44.40% 53.03B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.47%+1.04%+19.48%+69.17% 49.3B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.79%-0.27%-5.65%+36.06% 88.35B
Weighted average by Cap. -2.10%+0.15%+4.02%+44.65%

Financials

2027 *2028 *
Net sales 5M 4.48M 4.12M 3.73M 6.98M 475M 7.11M 49.12M 19.72M 250M 18.76M 18.37M 788M 10M 8.96M 8.24M 7.46M 13.95M 950M 14.21M 98.24M 39.44M 499M 37.53M 36.73M 1.58B
Net income 2.3M 2.06M 1.9M 1.72M 3.21M 218M 3.27M 22.61M 9.07M 115M 8.64M 8.45M 362M 6.23M 5.58M 5.13M 4.65M 8.69M 591M 8.85M 61.18M 24.56M 311M 23.37M 22.88M 981M
Net Debt - -
Projected Income Statement - Annual - Izotropic Corporation
Logo Izotropic Corporation
Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.
Employees
-
Date Price Change Volume
29/10/26 CA$0.1400 -3.45% 6,000
27/10/26 CA$0.1450 +3.57% 4,530
23/10/26 CA$0.1400 -12.50% 22,000

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Izotropic Corporation